glp-1 dietitian The Hub A Registered Dietitian's Guide to
Description
Inside, we cover the heavy hitters everyone's watching: Semaglutide, Tirzepatide, and the one to keep your eye on next, Orforglipron (Foundayo)
Featuring a powerful GLP-1 formula, this product is perfect for those looking to maintain overall well-being
If you're taking a GLP-1, you may not want to take it forever
Beyond these frontrunners, the pipeline is expanding: Novo Nordisk filed for FDA approval of CagriSema in 2025, the first once-weekly combination of GLP1 and amylin analogue
Explore the Ozempic microdosing trend, its unapproved use for weight loss, and expert warnings on safety and effectiveness.
Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.
